Literature DB >> 3436335

Evaluation of potential heart affine compounds by use of the isolated perfused rat heart.

G Kampf1, R Muenze, G Knop, S Seifert.   

Abstract

99mTc-organocation complexes were screened for heart affinity using the isolated perfused rat heart. The 99mTc-I compounds are better extracted by the heart and retained in it than the 99mTc-III compounds. 99mTcCl2(DMPE)2+ shows low uptake (15%) and fast washout, but no impairment of uptake after incubation with human serum albumin(HSA), with a modified preparation, initial uptake is not much better (18%) but washout is clearly diminished. 99mTc(DMPE)3+ is taken up to a greater extent (33%) if administered solely, but when given in conjunction with HSA, uptake decreases to about 4% because of strong affinity of the complex to the protein, but this compound persists well in the tissue. Detergents like tween 80 and dioctylsulphosuccinate are able to cause higher uptake of 99mTc(DMPE)3+ even in the presence of HSA, thus indicating a diminished binding of the compound to the protein. 99mTc(CN-t-butyl)6+ shows very high uptake (80%) by the heart, which is only moderately diminished by addition of HSA (to 38%), and persists excellently in the myocardium. Basic features of the compounds such as accumulation in and elimination from the myocardium as well as plasma protein binding and their mutual relationships are well reflected by the isolated heart model.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436335     DOI: 10.1007/BF00292494

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  5 in total

1.  Effects of reduced coronary flow on thallium-201 accumulation and release in an in vitro rat heart preparation.

Authors:  S Z Goldhaber; J B Newell; J S Ingwall; G M Pohost; N M Alpert; E T Fossel
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

2.  Cationic Tc-99m complexes as potential myocardial imaging agents.

Authors:  E Deutsch; K A Glavan; V J Sodd; H Nishiyama; D L Ferguson; S J Lukes
Journal:  J Nucl Med       Date:  1981-10       Impact factor: 10.057

3.  A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human.

Authors:  B L Holman; A G Jones; J Lister-James; A Davison; M J Abrams; J M Kirshenbaum; S S Tumeh; R J English
Journal:  J Nucl Med       Date:  1984-12       Impact factor: 10.057

4.  Biological studies of a new class of technetium complexes: the hexakis(alkylisonitrile)technetium(I) cations.

Authors:  A G Jones; M J Abrams; A Davison; J W Brodack; A K Toothaker; S J Adelstein; A I Kassis
Journal:  Int J Nucl Med Biol       Date:  1984

5.  Evaluation in dogs and humans of three potential technetium-99m myocardial perfusion agents.

Authors:  P Gerundini; A Savi; M C Gilardi; A Margonato; G Vicedomini; L Zecca; W Hirth; K Libson; J C Bhatia; F Fazio
Journal:  J Nucl Med       Date:  1986-03       Impact factor: 10.057

  5 in total
  3 in total

1.  Assessment of myocardial perfusion with Tc-99m: image is everything.

Authors:  Seth T Dahlberg
Journal:  J Nucl Cardiol       Date:  2009-04-30       Impact factor: 5.952

Review 2.  Myocardial kinetics of radiolabeled perfusion agents: basis for perfusion imaging.

Authors:  S T Dahlberg; J A Leppo
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

3.  99mTc-labelling of leucocytes with 99mTc-DPO: a complex developed for myocardial imaging.

Authors:  G Endert; U Franke; P Kleinert
Journal:  Eur J Nucl Med       Date:  1989
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.